{"disease":{"id":"antithrombin-iii-deficiency","name":"antithrombin iii deficiency"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04899232","title":"Antithrombin III in Infectious Disease Caused by COVID-19","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":52,"lead_sponsor_name":"Enrique Ginzburg","has_results":true},{"nct_id":"NCT04879550","title":"Prospective Investigation of Antithrombin III Deficiency in Adult Patients With ECMO","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}